Smith & Nephew plc vs Ishares Msci Thailand Etf — how do they compare? Smith & Nephew plc trades at $27.96 (market cap $11.62B), while Ishares Msci Thailand Etf trades at $74.77. The key difference: Smith & Nephew plc pays a 2.86% dividend while Ishares Msci Thailand Etf pays none, and Ishares Msci Thailand Etf is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | THD | |
|---|---|---|
Market Cap | $11.62B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $38.53 | $75.06 |
52-Week Low | $27.80 | $57.86 |
Enterprise Value | $14.66B | — |
Dividend Yield | 2.86% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
THD trades at $75.06, up 2.28% today, with a bearish technical signal from moving averages but neutral oscillators. The stock lacks disclosed valuation ratios like P/E and P/S, with a dividend scheduled for June 2026. Recent news highlights its outperformance among ASEAN ETFs, driven by AI hardware exposure, but notes vulnerability to profit-taking.
The outlook is mixed: THD benefits from AI-driven growth but faces risks from regional economic shifts and high dependence on tech cycles. Investors should weigh its strong returns against potential volatility from foreign capital flows and competitive pressures in Asian markets.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →